Table 2.
Participant characteristics by rescheduling status.
| Factor | Not Rescheduled (N = 18) | Rescheduled (N = 87) | p-value |
|---|---|---|---|
| Age, median (IQR) | 63.5 (58, 71) | 60 (55, 68) | 0.16 |
| Sex | 0.80 | ||
| Female | 10 (56%) | 52 (60%) | |
| Male | 8 (44%) | 35 (40%) | |
| Race | 0.12 | ||
| White | 17 (94%) | 80 (92%) | |
| Black | 0 (0%) | 7 (8%) | |
| Asian | 1 (6%) | 0 (0%) | |
| Smoking status | 0.28 | ||
| Current | 2 (11%) | 4 (5%) | |
| Former | 3 (17%) | 27 (31%) | |
| Never | 13 (72%) | 56 (64%) | |
| Alcohol use | 0.20 | ||
| Current | 4 (22%) | 37 (43%) | |
| Former | 2 (11%) | 13 (15%) | |
| Never | 12 (67%) | 37 (43%) | |
| Personal cancer history | 0.034 | ||
| No | 15 (83%) | 48 (55%) | |
| Yes | 3 (17%) | 39 (45%) | |
| Jewish ancestry | 0.23 | ||
| No | 11 (61%) | 67 (77%) | |
| Yes | 7 (39%) | 20 (23%) | |
| Relatives with PDAC | 0.19 | ||
| 0–1 | 2 (11%) | 28 (32%) | |
| 2 | 10 (56%) | 35 (40%) | |
| 3+ | 6 (33%) | 24 (28%) | |
| High-risk category | 0.40 | ||
| Familial PDAC without a known disease-causing gene variant | 12 (67%) | 42 (48%) | |
| Disease-causing gene variant (ATM, BRCA1, BRCA2, PALB2, or Lynch syndrome genes) with PDAC family history |
6 (33%) | 34 (39%) | |
| CDKN2A | 0 (0%) | 9 (10%) | |
| Other | 0 (0%) | 2 (2%) | |
| First surveillance EUS | 2 (11%) | 18 (21%) | 0.35 |
| Pancreatic abnormality on prior surveillance exam | 6 (33%) | 21 (24%) | 0.75 |
| Number of prior surveillance exams, median (IQR) | 2.5 (2, 4) | 2 (1, 4) | 0.46 |
| Time in surveillance (months), median (IQR) | 28.9 (12.3, 46.8) | 22.8 (10.0, 45.4) | 0.42 |